查看購物車
  • Simplified Chinese
  • Japanese
  • Korean
女性健康診斷市場－全球展望與2030年預測
市場調查報告書
商品編碼
1771762

女性健康診斷市場－全球展望與2030年預測

Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030
出版日期: | 出版商: Kalorama Information | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

《女性健康診斷市場－全球展望與2030年預測》提供全面的資料驅動分析，涵蓋臨床、即時診斷（POC）和非處方（OTC）領域，涵蓋女性健康診斷檢測的全球格局。隨著全球人口結構的變化以及女性壽命的延長，醫療保健系統必須認識並解決疾病風險、篩檢和治療方面的性別差異。診斷是這一轉變的核心，能夠在女性的整個生命週期中提供個人化和及時的干預措施。

本詳細報告預測了2030年全球診斷檢測和診斷系統的市場趨勢，並對與女性健康相關的各種診斷類別進行了區域細分和趨勢分析。本研究涵蓋了用於檢測、篩檢和監測女性特有疾病或在女性中高度流行的疾病的現有技術和新興技術。市場規模反映產品和系統的銷售，包括設備安裝和軟體支援等相關服務。

本報告涵蓋的主要診斷領域包括：

  • 乳房和生殖健康影像：乳房X光檢查、CADe/CADx、產科超音波、乳房超音波成像
  • 產前檢測和帶因者篩檢：非侵入性產前檢測（NIPT）、帶因者篩檢、母胎診斷
  • 傳染病和性傳染病：HPV 診斷、TORCH 免疫測定、分子泌尿道感染（UTI）檢測
  • 不孕症與懷孕檢驗：排卵、排卵荷爾蒙的實驗室和即時檢測、懷孕狀態
  • 癌症與慢性病監測：巴氏抹片檢查、卵巢癌生物標記、女性特異性自體免疫免疫測定
  • 骨骼健康與預防診斷：骨密度檢測與早期癌症檢測的陰道鏡系統

每一章都探討了推動每個類別成長的科學基礎和技術創新，並應對了監管變化、償付、市場准入和產品差異化等挑戰。本報告基於對行業專家的訪談、臨床實驗室的意見以及廣泛的一手和二手研究，提供市場預測和趨勢評估。

每個類別都介紹了各種的診斷公司，從主導的跨國公司到靈活的利基市場參與者。這些公司包括BD、GE Healthcare、Hologic、Roche、Siemens Healthineers、Thermo Fisher等。這些公司正透過生物標記、自動化、數位成像、家用檢測等領域的創新，積極塑造女性診斷的未來。

鑑於診斷測試目前驅動著超過 70%的醫療決策，本報告不僅將女性健康診斷定位為一個不斷成長的市場，而且還將其定位為精準醫療的關鍵組成部分。本報告所包含的見解對於致力於擴大獲取途徑、改善臨床結果以及投資符合女性不斷變化的健康需求的下一代診斷解決方案的利益相關者非常重要。

目錄

關於研究公司

第1章 執行摘要

第2章 引言

  • 女性健康：進步空間
  • 女性健康視角
  • 某些疾病在女性和男性的發展方式不同
    • 疼痛
    • 心臟
    • 大腦
    • 情緒
    • 骨骼結構
    • 酒精
    • 藥物副作用
    • 吸煙
    • 生育能力
    • 性傳染病與愛滋病毒
    • 自體免疫疾病
    • 癌症
    • 女性較常見的癌症
    • 肌肉骨骼健康
    • 出生缺陷
    • 泌尿道感染泌尿道感染（UTI）
  • 女性健康篩檢的主要趨勢與挑戰
    • 卵巢癌診斷與生物標記
    • HPV 檢測
    • 更廣泛的帶因者篩檢和非侵入性產前檢測（NIPT）
    • 泌尿道感染的多重與分子檢測
    • 影像學與人工智慧
    • 懷孕和排卵
    • 自體免疫檢測

第3章 乳房 X 光攝影

  • 簡介
  • 乳房 X 光攝影市場
  • 電腦輔助偵測/診斷（CADe/CADx）
  • 乳房成像中的人工智慧引進
  • 監理變化
  • 競爭格局
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

第4章 超音波

  • 簡介
  • 婦產科
  • 乳房成像
  • 市場趨勢
  • 婦產科超音波趨勢
  • 乳房影像市場
  • 競爭格局
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

第5章 產前和帶因者篩檢

  • 簡介
  • 非侵入性產前檢測（NIPT）
  • 遺傳學的進步帶來新的挑戰
  • 攜帶者篩檢
  • 檢測採用趨勢
  • 遺傳性疾病
  • 併購與合作
  • 非侵入性產前檢測（NIPT）和帶因者篩檢市場
  • 競爭格局
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

第6章 HPV 檢測

  • 簡介
  • 概述
  • HPV 體外診斷檢測市場
  • HPV 檢測與全球篩檢項目
  • 競爭格局
    • BD (Becton, Dickinson and Company)
    • Hologic
    • QIAGEN
    • Roche

第7章 妊娠與排卵

  • 簡介
  • 偵測視角
  • 數位化檢測
  • 實驗室檢測
  • 趨勢
  • 市場
  • 產品
  • TORCH檢測
  • 競爭格局
    • 市場參與者
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • 主要公司
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

第8章 巴氏抹片檢測

  • 簡介
  • 子宮頸癌檢測
  • 趨勢
  • 巴氏抹片檢測市場
  • 競爭格局
    • BD (Becton Dickinson)
    • Hologic

第9章 自體免疫疾病疾病

  • 引言
  • 遺傳因素
  • 對女性患者的影響
  • 近期趨勢
  • 女性自體免疫疾病實驗室免疫測定市場
  • 競爭格局
    • Bio-Rad
    • Euroimmun（Revvity）
    • Thermo Fisher Scientific

第10章 骨密度檢測

  • 引言
  • 骨質疏鬆症發生率驚人成長
  • 推動骨密度測量需求
  • 雙能量X光骨密度儀（DEXA）及競爭技術趨勢
  • 骨密度檢測市場
  • 競爭格局
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

第11章 陰道鏡檢查

  • 簡介
  • 子宮頸癌篩檢與診斷
  • 趨勢
  • 陰道鏡系統市場
  • 競爭格局
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

第12章 泌尿道感染

  • 簡介
  • 發病率和死亡率的主要原因
  • 影響
  • 趨勢
  • 技術進步超越臨床指南
  • 次世代定序（NGS）
  • 多重PCR、qPCR
  • 尿路感染分子檢測市場
  • 競爭格局
    • 中小企業機會
    • 公司亮點
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

第13章 卵巢癌

  • 簡介
  • 卵巢癌的類型
  • CA-125
  • 趨勢
  • 多變量指數分析與基因組檢測
  • 卵巢癌生物標記市場
  • 競爭格局
    • 公司亮點
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific
簡介目錄
Product Code: 25-072KA

Kalorama Information's "Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030" offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women's health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift-with women living longer than men-healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman's life span.

This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.

Key diagnostic sectors covered in the report include:

  • Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
  • Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
  • Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
  • Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
  • Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
  • Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.

Each chapter explores the scientific foundations and technological innovations driving growth in its respective category while addressing challenges such as regulatory shifts, reimbursement, market access, and product differentiation. The report draws on interviews with industry experts, input from clinical labs, and extensive primary and secondary research to inform market forecasts and trend assessments.

A diverse group of diagnostic players-ranging from dominant multinationals to nimble niche firms-are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.

At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women's health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women's evolving health needs.

Table of Contents

About Kalorama Information

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Market Overview and Potential
    • Figure 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
    • Table 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]

Chapter 2: Introduction

  • Female Health: Room for Improvement
  • Perspective on Women's Health
  • Women and Men Develop Some Diseases Differently
    • Pain
    • The Heart
    • The Brain
    • Emotions
    • Bone Structure
    • Alcohol
    • Drug Side Effects
    • Smoking
    • Fertility
    • STIs and HIV
    • Autoimmune Disease
    • Cancer
    • Leading Female Cancers
    • Musculoskeletal Health
    • Congenital Abnormalities
    • Urinary Tract Infections (UTIs)
  • Key Trends and Issues in Women's Health Diagnostics
    • Ovarian Cancer Diagnostics and Biomarkers
    • HPV Testing
    • Broader Carrier Screening and NIPT
    • Multiplex and Molecular Testing for UTIs
    • Imaging and AI
    • Pregnancy and Ovulation
    • Autoimmune Laboratory Immunoassays

Chapter 3: Mammography

  • Introduction
    • Transition to Digital
    • Economics of Routine Screening
    • Digital Breast Tomosynthesis (DBT or 3D Mammography)
  • Mammography Market
    • Table 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-2: World Mammography Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-3: World Mammography Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Computer-Aided Detection/Diagnosis (CADe/CADx)
    • Table 3-2: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-4: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-5: World CADe/CADx Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-6: World CADe/CADx Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Artificial Intelligence Adoption in Breast Imaging
    • Key Trends in AI-Driven CAD
    • Trends
  • Regulatory Changes
  • Competitive Landscape
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

Chapter 4: Ultrasound

  • Introduction
    • Table 4-1: Key Applications for Medical Ultrasound
  • Obstetrics and Gynecology
  • Breast Imaging
  • Market Trends
  • Obstetric and Gynecological Ultrasound Trends
    • Table 4-2: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-1: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-2: World Ultrasound OB/GYN Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-3: World Ultrasound OB/GYN Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Breast Imaging Market
    • Table 4-3: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-4: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-5: World Ultrasound Breast Imaging Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-6: World Ultrasound Breast Imaging Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

Chapter 5: Prenatal and Carrier Screening

  • Introduction
  • NIPT
  • Advances in Genetics Bring New Challenges
  • Carrier Screening
  • Test Adoption Trends
  • Inherited Diseases
    • Inflammatory Bowel Disease (IBD) and Crohn's Disease
    • Autism Spectrum Disorder (ASD)
    • Alzheimer's Disease (AD)
    • Cardiovascular Disease (CVD)
    • Psychiatric Disorders
  • M&A, Partnerships
  • NIPT and Carrier Screening Markets
    • Table 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-2: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 5-3: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

Chapter 6: HPV Testing

  • Introduction
  • Overview
    • HPV Infection
    • Infection in Females
    • High-Risk Types and Cervical Cancer
    • HPV Testing
  • HPV IVD Test Market
    • Table 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-2: World Female HPV IVD Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 6-3: World Female HPV IVD Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • HPV Testing and Global Screening Programs
  • Competitive Landscape
    • BD (Becton, Dickinson and Company)
    • Hologic
    • QIAGEN
    • Roche

Chapter 7: Pregnancy and Ovulation

  • Introduction
  • Perspective on Testing
  • Digital Testing
  • Lab Testing
  • Trends
  • Market
    • POC Pregnancy and Fertility Test Market
      • Table 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-2: World POC Pregnancy Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-3: World POC Pregnancy Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
      • Table 7-2: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-4: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-5: World Lab-Based Fertility Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-6: World Lab-Based Fertility Immunoassay Market, Share by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Products
  • TORCH Testing
    • Table 7-3: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-7: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-8: World Lab-Based TORCH Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 7-9: World Lab-Based TORCH Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Market Participants
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • Major Companies
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

Chapter 8: Pap Smears

  • Introduction
  • Testing for Cervical Cancer
  • Trends
  • Pap Test Market
    • Table 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-2: World IVD Traditional Pap Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 8-3: World IVD Traditional Pap Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • BD (Becton Dickinson)
    • Hologic

Chapter 9: Autoimmune Disease

  • Introduction
  • Genetic Factors
  • Impact on Female Patients
  • Recent Developments
  • Female Autoimmune Lab-Based Immunoassay Market
    • Table 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-2: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World] ($ million)
    • Figure 9-3: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Bio-Rad
    • Euroimmun (Revvity)
    • Thermo Fisher Scientific

Chapter 10: Bone Density Testing

  • Introduction
  • Alarming Rise in Osteoporosis
  • Propelling the Need for Measurement
  • Trends in DEXA and Competing Technologies
    • DEXA: The Gold Standard
    • Emerging Trends and Accessibility
  • Bone Densitometry Market
    • Table 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-2: World Bone Densitometry for Female Testing Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 10-3: World Bone Densitometry for Female Testing Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

Chapter 11: Colposcopy

  • Introduction
  • Cervical Cancer Screening and Diagnosis
  • Trends
  • Colposcopy Systems Market
    • Table 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-2: World Colposcopy Systems Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 11-3: World Colposcopy Systems Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

Chapter 12: Urinary Tract Infections

  • Introduction
  • Leading Cause of Morbidity and Death
  • Impact
  • Trends
  • Technological Advances Outpace Clinical Guidelines
  • Next-Generation Sequencing (NGS)
  • Multiplex PCR, qPCR
  • UTI Molecular Test Market
    • Table 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-2: World Molecular UTI Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 12-3: World Molecular UTI Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Potential in Small Companies
    • Company Highlights
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

Chapter 13: Ovarian Cancer

  • Introduction
  • Types of Ovarian Cancer
  • CA-125
  • Trends
  • Multivariate Index Assays and Genomic Tests
  • Ovarian Cancer Biomarker Market
    • Table 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-2: World Ovarian Cancer Biomarkers Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 13-3: World Ovarian Cancer Biomarkers Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Company Highlights
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific